ELITEK (rasburicase) Patient Assistance Program
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Elitek (rasburicase) is FDA-approved for the initial management of plasma uric acid levels in adult and pediatric patients with leukemia, lymphoma, and solid tumor malignancies receiving anticancer therapy expected to result in tumor lysis syndrome and hyperuricemia. It is a recombinant urate oxidase enzyme.
- Without assistance, Elitek costs commonly run approximately $5,500–$8,500 per single dose (3 or 7.5 mg vial).
- Through AffordMyPrescriptions, qualifying patients can access Elitek for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no biosimilar of Elitek in the U.S. as of 2026. Alternative tumor lysis syndrome (TLS) management includes generic allopurinol (oral xanthine oxidase inhibitor — used for TLS prophylaxis in lower-risk patients; cheap), febuxostat (Uloric, generic — also oral xanthine oxidase inhibitor; used in patients intolerant to allopurinol), aggressive IV hydration, and electrolyte management. Elitek's role is in high-risk TLS or established hyperuricemia where rapid urate reduction is critical.
What Is Elitek Prescription Assistance Program?
The Elitek Prescription Assistance Program is a manufacturer-sponsored initiative that provides Elitek at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for high-risk TLS patients who are uninsured or underinsured, as well as Medicare beneficiaries.
Navigating the program on your own means dealing with eligibility verification, oncology/hematology coordination, prior-authorization documentation (often retrospective due to urgent inpatient use), hospital billing, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment.
Pharmacy Price Comparison
- Without assistance, Elitek costs roughly $5,500–$8,500 per dose. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Hospital pharmacy | ~$8,000/dose | Save substantially |
| Inpatient billing | ~$8,500/dose | Save substantially |
| Specialty Pharmacy | ~$6,500/dose | Save substantially |
| Walmart | ~$6,000/dose | Save substantially |
Costco | ~$5,800/dose | Save substantially |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Elitek Prescription Program?
The Patient Assistance Program is free to apply for and provides Elitek at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Elitek:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $5,500–$8,500 per dose per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Elitek assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Elitek Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Elitek:
Elitek (rasburicase) is a recombinant urate oxidase enzyme used to rapidly lower plasma uric acid in patients at high risk for tumor lysis syndrome (TLS) — a potentially life-threatening complication of cancer treatment where rapid tumor cell death releases massive amounts of intracellular contents (uric acid, potassium, phosphate, calcium) into the bloodstream.
How Elitek Works:
Tumor lysis syndrome (TLS) is a metabolic emergency where massive cancer cell death releases intracellular contents like purines, phosphorus, and potassium into the blood. Purines metabolize into uric acid, which can crystallize in renal tubules and cause acute kidney injury, alongside dangerous electrolyte imbalances like hyperkalemia and hypocalcemia. Because humans lack functional urate oxidase to break down uric acid, rasburicase is used as a recombinant enzyme to quickly convert uric acid into a highly soluble substance called allantoin. This rapid reduction in uric acid burden helps clear the kidneys and prevents severe complications like acute renal failure, cardiac arrhythmias, and seizures.
Form and use:
Elitek is administered as an intravenous (IV) infusion over 30 minutes, given once daily for up to 5 days at a weight-based dose of 0.2 mg/kg/day. Healthcare providers frequently utilize a single-dose strategy, giving one weight-based dose and only administering additional doses if follow-up lab results show they are necessary. The medication comes in 3 mg or 7.5 mg vials that must be reconstituted before patient use. Because of severe drug interactions, G6PD testing should ideally be performed on the patient before starting this treatment whenever feasible.
Generic availability:
As of 2026, there is no biosimilar version of Elitek available in the United States. For lower-risk patients needing TLS prophylaxis, generic oral allopurinol is a much cheaper alternative, though it has a slower onset and is less effective for rapid urate reduction. Generic febuxostat is another oral option that serves as an alternative xanthine oxidase inhibitor for patients who cannot tolerate allopurinol. Essential supportive measures for TLS management include IV hydration and close electrolyte management, while pegloticase—another recombinant uricase—is reserved strictly for chronic gout and is not used for acute TLS.
Warnings:
Elitek carries severe boxed warnings for anaphylaxis, life-threatening methemoglobinemia, and acute hemolysis in patients with G6PD deficiency. Because rasburicase oxidizes hemoglobin in G6PD-deficient red blood cells, the drug is strictly contraindicated in these individuals, making pre-screening especially vital for patients of African, Mediterranean, or Southeast Asian descent. Additionally, the medication interferes with laboratory uric acid measurements because the drug will continue converting uric acid to allantoin inside the blood collection tube. To prevent falsely low lab results, blood samples must be placed on ice immediately and tested promptly by the laboratory.
FAQ (Frequently Asked Questions)
How Much Does Elitek Cost Without Insurance?
Elitek costs approximately $5,500–$8,500 per single dose. Most patients receive 1 dose (sometimes up to 5 daily doses for severe TLS). Through AffordMyPrescriptions, qualifying patients receive Elitek at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
What Is Tumor Lysis Syndrome?
TLS is a metabolic emergency from massive tumor cell death — releasing potassium, phosphate, and uric acid into the bloodstream. The uric acid can crystallize in kidneys causing acute renal failure; high potassium can cause fatal arrhythmias. Prevention and treatment include aggressive IV hydration, electrolyte management, and uric acid-lowering therapy (allopurinol for prevention; rasburicase for high-risk or established TLS).
Who Is High-Risk For TLS?
Patients with bulky, rapidly proliferating cancers — particularly acute leukemias with high blast counts, Burkitt or other high-grade lymphomas, large bulky lymphomas with high LDH, advanced CLL receiving venetoclax. Patients with pre-existing renal impairment, elevated baseline uric acid, or dehydration have additional risk. Risk assessment guides whether to use rasburicase (high-risk) or allopurinol (intermediate-risk).
Why Do I Need G6PD Testing?
Rasburicase generates hydrogen peroxide as a byproduct of converting uric acid to allantoin. G6PD-deficient red blood cells can’t detoxify hydrogen peroxide adequately — leading to oxidative damage and severe acute hemolysis. G6PD deficiency is more common in patients of African, Mediterranean, and Southeast Asian descent. G6PD testing before rasburicase is recommended when feasible — though urgent TLS situations may not allow time.
How Is Elitek Different From Allopurinol?
Allopurinol (oral, generic) blocks new uric acid formation by inhibiting xanthine oxidase — but does NOT lower existing uric acid. Takes days to weeks for full effect. Used for TLS prophylaxis. Elitek (rasburicase, IV) actively breaks down existing uric acid via urate oxidase — dramatically lowers uric acid within hours. Used for high-risk TLS prevention or established severe hyperuricemia. Both have a role; rasburicase is used when rapid uric acid reduction is critical.
Can I Get Help With The Hospital Bill?
Yes — Elitek administration during inpatient cancer treatment is typically billed as part of the hospitalization. Manufacturer PAP may apply retrospectively for eligible uninsured/underinsured patients. Hospital charity programs and independent foundations may help. Our advocacy can coordinate.
What If My Application Is Denied?
If denied, we explore alternatives — generic allopurinol for prevention/treatment (much cheaper but slower onset), hospital charity programs, the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Leukemia & Lymphoma Society, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Elitek, our team may be able to help you access assistance programs designed to make brand TLS therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.